Drug-induced readthrough of premature stop codons leads to the stabilization of laminin alpha2 chain mRNA in CMD myotubes.

J Gene Med 2008 Feb;10(2):217-24

Inserm, U582, Paris, France.

Background: The most common form of congenital muscular dystrophy is caused by a deficiency in the alpha2 chain of laminin-211, a protein of the extracellular matrix. A wide variety of mutations, including 20 to 30% of nonsense mutations, have been identified in the corresponding gene, LAMA2. A promising approach for the treatment of genetic disorders due to premature termination codons (PTCs) is the use of drugs to force stop codon readthrough.

Methods: Here, we analyzed the effects of two compounds on a PTC in the LAMA2 gene that targets the mRNA to nonsense-mediated RNA decay, in vitro using a dual reporter assay, as well as ex vivo in patient-derived myotubes.

Results: We first showed that both gentamicin and negamycin promote significant readthrough of this PTC. We then demonstrated that the mutant mRNAs were strongly stabilized in patient-derived myotubes after administration of negamycin, but not gentamicin. Nevertheless, neither treatment allowed re-expression of the laminin alpha2-chain protein, pointing to problems that may have arisen at the translational or post-translational levels.

Conclusions: Taken together, our results emphasize that achievement of a clinical benefit upon treatment with novel readthrough-inducing agents would require several favourable conditions including PTC nucleotide context, intrinsic and induced stability of mRNA and correct synthesis of a full-length active protein.

Download full-text PDF

Source
http://dx.doi.org/10.1002/jgm.1140DOI Listing
February 2008
8 Reads

Publication Analysis

Top Keywords

alpha2 chain
8
vivo patient-derived
4
patient-derived myotubesresults
4
myotubesresults gentamicin
4
gentamicin negamycin
4
well vivo
4
dual reporter
4
reporter assay
4
assay well
4
negamycin promote
4
promote readthrough
4
stabilized patient-derived
4
patient-derived myotubes
4
myotubes administration
4
mrnas stabilized
4
mutant mrnas
4
readthrough ptc
4
ptc demonstrated
4
demonstrated mutant
4
vitro dual
4

References

(Supplied by CrossRef)

Fardeau et al.
1992

Banker et al.
1994

Tomé et al.
1998

Tomé et al.
Neuroped 1999

Helbling-Leclerc et al.
Nat Genet 1995

Nissinen et al.
Am J Hum Genet 1996

Allamand et al.
Eur J Hum Genet 2002

Allamand et al.
Hum Mol Genet 1997

Guicheney et al.
Neuromuscul Disord 1997

Palmer et al.
Nature 1979

Singh et al.
Nature 1979

Similar Publications